Although chronic inflammation and NLRP3 inflammasome activation have been implicated in atherosclerosis and fatty liver disease, whether SREBP-1c is involved in regulating NLRP3 and IL-1β expression in HGFs remains largely unknown. This evidence concerns the gene SREBF1 and fatty liver disease.